Abstract
4-(Z)-((2-Hydroxy-4-oxopent-2-en-3-yl)diazenyl)-N-(5-methylisoxazol-3-yl)benzene sulfonamide (HL) and its nickel(II) complex [Ni(L)2(H2O)4] have been characterized by spectroscopic and single crystal X-ray diffraction measurements. Time dependent DFT computations have been used to explain the electronic spectra of the compounds. The interaction of CT DNA with [Ni(L)2(H2O)4] (Kb, 12.20×105M−1) is stronger than with HL (Kb, 6.09×105M−1). The antimicrobial activity of HL and the Ni(II) complex has been examined against Bacillus subtilis (ATCC 6633; IC50: 63.72μg/ml (HL) and 81.49μg/ml ([Ni(L)2(H2O)4])) and Escherichia coli (ATCC 8739; IC50: 77.25μg/ml (HL) and 78.28μg/ml ([Ni(L)2(H2O)4])). The in-silico test of HL with DHPS protein from E. coli helps in understanding the drug metabolism and has explained the drug–molecule interaction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
